• According to Transparency Market Research’s latest report on the global diabetes devices market for the historical period 2017–2018 and forecast period 2019–2027, increase in prevalence of diabetes, and increase in adoption of insulin pumps among type 1 diabetes patients are projected to drive the global diabetes devices market during the forecast period
  • According to the report, the global diabetes devices market was valued at US$ 41.8 Bn in 2018 and is anticipated to expand at a CAGR of 6.4% from 2019 to 2027

To know the scope of our report Get a Sample on Diabetes Devices Market?

Increase in Prevalence of Diabetes Expected to Drive Global Diabetes Devices Market: Key Drivers

  • Prevalence of diabetes is expected to increase exponentially worldwide due to change in lifestyle and various factors such as malnutrition, genetic mutations, and others. According to various government and private organizations operating in the diabetes industry, diabetes is considered one of the top fatal diseases. For instance, according to the American Diabetes Association, diabetes accounts for nearly 71,000 deaths in the U.S. each year. About 1 in 11 adults in the country suffers from diabetes.
  • Rise in prevalence of diabetes across the U.S. and Asia is anticipated to boost the growth of the diabetes management market due to a relative increase in demand for insulin delivery devices
  • According to the International Diabetes Federation, 422 million people across the world were living with diabetes in 2016, and over 10% of the world’s adult population, or around 642 million people, will have diabetes by 2040. Hence, increase in the diabetic population in Asia and the U.S. is expected to propel the diabetes devices market.

Get a glimpse of the in-depth analysis through our Report Brochure

Increase in Adoption of Insulin Pump among Type 1 Diabetes Patients Boost Market Growth

  • Over the last decade, Type 1 diabetes has been one of the increasing in major healthcare concern for many countries. Countries like the U.S., China, U.K, and Germany have seen increasing rates of T1 incidences.
  • Type 1 diabetes (T1D) is type of autoimmune disease which occurs in children and adults in which pancreas stops producing insulin. The increasing incidences of Type 1 diabetes (T1D) among the children’s is one of the major healthcare concern. For instance, according to IDF, in 2015 Europe region had 140,000 children’s (0-14 years) with Type-1 Diabetes and 21,600 new cases diagnosed every year.
  • Type-1 diabetes patients majorly use the insulin pen or insulin pumps. Insulin pumps are relatively costly as compared to other insulin delivery devices. However, the adoption of insulin pumps among is increasing gradually in many developing and developed countries.
  • This increasing incidences of type-1 diabetes in developing and developed countries are expected to drive the growth of the global insulin pumps market.

Threat of Alternative Therapies for Diabetes to Hamper Market

  • Diabetes is a dreadful disease that is becoming a serious threat to human health. Rise in obesity and sedentary lifestyle have become a major cause of increasing diabetes prevalence across the world.
  • Various treatments and drugs are available for diabetes. However, total recovery from diabetes is still a matter of concern. Alternative to synthetic agents, natural cure by plants provides a potential source curing complications of hypoglycemia.
  • Other alternative therapies such as acupuncture, diabetic supplements, hydrotherapy, and yoga are practiced for treatment of diabetes and have no side effects
  • These emerging alternative therapies are likely to act as major restraints of the diabetes device market

Expanding operations in future? To get the perfect launch ask for a custom report 

Global Diabetes Devices Market: Competitive Landscape

  • This report profiles major players in the global diabetes devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global diabetes devices market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global diabetes devices market are
    • Medtronic
    • Novo Nordisk A/S
    • Sanofi
    • Eli Lilly and Company
    • F. Hoffmann-La Roche Ltd.
    • Becton
    • Dickinson and Company
    • Tandem Diabetes Care, Inc.
    • Abbott Laboratories
    • Cellnovo
    • Insulet Corporation
    • LifeScan, Inc.
    • Owen Mumford Ltd.

Global Diabetes Devices Market: Key Developments

Key players in the global diabetes devices market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global diabetes devices market. A few expansion strategies adopted by players operating in the global diabetes devices market are:

  • In January 2020, Tandem Diabetes Care Inc. launched slim X2 insulin pump with Control-IQ technology. The device comes with an advanced hybrid-closed loop feature designed to help increase time in range (70-180 mg/dL).
  • In May 2019, Roche Diabetes Care India launched Accu-Chek, a blood glucose monitoring system, and “mySugr” app aimed at betterment of people with diabetes.
  • In June 2017, Medtronic the company launched MiniMed 670G system. It is based on Hybrid Closed Loop system for people with type 1 diabetes.
  • In April 2017, Cellnova delivers first commercial batch of insulin cartridges with manufacturing partner, flex.

The report on the global diabetes devices market discussed individual strategies, followed by company profiles of manufacturers of diabetes devices. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global diabetes devices market.

Global Diabetes Devices Market – Segmentation

Product Type

Glucose Monitoring Devices

  • Self- monitoring blood glucose meters
  • Blood glucose testing strips
  • Lancets
  • Continuous glucose monitoring meters

Insulin Delivery Devices

  • Insulin syringes
  • Insulin pens
  • Insulin pumps

Diabetes Management Software

Artificial Pancreas System

Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Diabetes Clinics/Centres

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

The global diabetes devices market was worth US$ 41.8 Bn and is projected to reach a value of US$ 73.4 Bn by the end of 2027

Diabetes devices market is anticipated to grow at a CAGR of 6.4% during the forecast period

North America accounted for a major share of the global diabetes devices market

Diabetes devices market is driven by increase in prevalence of diabetes, and increase in adoption of insulin pumps among type 1 diabetes patients are projected to drive the global market during the forecast period

Key players in the global diabetes devices market include Medtronic, Novo Nordisk A/S, Sanofi, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Tandem Diabetes Care, Inc., Abbott Laboratories, Cellnovo, Insulet Corporation, LifeScan, Inc., Owen Mumford Ltd

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Diabetes Devices Market

4. Market Overview

    4.1. Introduction

        4.1.1. Diabetes Devices Market Introduction

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Diabetes Devices Market Analysis and Forecasts, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Value Chain Analysis

    5.2. Estimated Number of People with Diabetes Worldwide and Per Region in 2015 and 2040 (Age 20-79 years) 

    5.3. Emerging Technologies in Diabetes Management

6. Global Diabetes Devices Market Analysis and Forecasts, by Product Type 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast by Product Type, 2017–2027

        6.3.1. Glucose Monitoring Devices

            6.3.1.1. Self- monitoring blood glucose meters

            6.3.1.2. Blood glucose testing strips

            6.3.1.3. Lancets

            6.3.1.4. Continuous glucose monitoring meters

        6.3.2. Insulin Delivery Devices

            6.3.2.1. Insulin syringes

            6.3.2.2. Insulin pens

            6.3.2.3. Insulin pumps

        6.3.3. Diabetes Management Software

        6.3.4. Artificial Pancreas System

    6.4. Market Attractiveness by Product Type 

7. Global Diabetes Devices Market Analysis and Forecasts, by Distribution Channel 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast by Distribution Channel, 2017–2027

        7.3.1. Hospital Pharmacies

        7.3.2. Retail Pharmacies

        7.3.3. Online Pharmacies

        7.3.4. Diabetes Clinics/Centres

    7.4. Market Attractiveness by Distribution Channel 

8. Global Diabetes Devices Market Analysis and Forecasts, by Region

    8.1. Key Findings

    8.2. Market Value Forecast by Region

        8.2.1. North America 

        8.2.2. Europe 

        8.2.3. Asia Pacific 

        8.2.4. Latin America 

        8.2.5. Middle East & Africa 

    8.3. Market Attractiveness by Country/Region

9. North America Diabetes Devices Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast by Product Type, 2017–2027

        9.2.1. Glucose Monitoring Devices

            9.2.1.1. Self- monitoring blood glucose meters

            9.2.1.2. Blood glucose testing strips

            9.2.1.3. Lancets

            9.2.1.4. Continuous glucose monitoring meters

        9.2.2. Insulin Delivery Devices

            9.2.2.1. Insulin syringes

            9.2.2.2. Insulin pens

            9.2.2.3. Insulin pumps

        9.2.3. Diabetes Management Software

        9.2.4. Artificial Pancreas System

    9.3. Market Value Forecast by Distribution Channel, 2017–2027

        9.3.1. Hospital Pharmacies

        9.3.2. Retail Pharmacies

        9.3.3. Online Pharmacies

        9.3.4. Diabetes Clinics/Centres

    9.4. Market Value Forecast by Country, 2017–2027

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis 

        9.5.1. By Product Type 

        9.5.2. By Distribution Channel 

        9.5.3. By Country

10. Europe Diabetes Devices Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast by Product Type, 2017–2027

        10.2.1. Glucose Monitoring Devices

            10.2.1.1. Self- monitoring blood glucose meters

            10.2.1.2. Blood glucose testing strips

            10.2.1.3. Lancets

            10.2.1.4. Continuous glucose monitoring meters

        10.2.2. Insulin Delivery Devices

            10.2.2.1. Insulin syringes

            10.2.2.2. Insulin pens

            10.2.2.3. Insulin pumps

        10.2.3. Diabetes Management Software

        10.2.4. Artificial Pancreas System

    10.3. Market Value Forecast by Distribution Channel, 2017–2027

        10.3.1. Hospital Pharmacies

        10.3.2. Retail Pharmacies

        10.3.3. Online Pharmacies

        10.3.4. Diabetes Clinics/Centres

    10.4. Market Value Forecast by Country/Sub-region, 2017–2027

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis 

        10.5.1. By Product Type 

        10.5.2. By Distribution Channel 

        10.5.3. By Country/Sub-region

11. Asia Pacific Diabetes Devices Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast by Product Type, 2017–2027

        11.2.1. Glucose Monitoring Devices

            11.2.1.1. Self- monitoring blood glucose meters

            11.2.1.2. Blood glucose testing strips

            11.2.1.3. Lancets

            11.2.1.4. Continuous glucose monitoring meters

        11.2.2. Insulin Delivery Devices

            11.2.2.1. Insulin syringes

            11.2.2.2. Insulin pens

            11.2.2.3. Insulin pumps

        11.2.3. Diabetes Management Software

        11.2.4. Artificial Pancreas System

    11.3. Market Value Forecast by Distribution Channel, 2017–2027

        11.3.1. Hospital Pharmacies

        11.3.2. Retail Pharmacies

        11.3.3. Online Pharmacies

        11.3.4. Diabetes Clinics/Centres

    11.4. Market Value Forecast by Country/Sub-region, 2017–2027

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Market Attractiveness Analysis 

        11.5.1. By Product Type 

        11.5.2. By Distribution Channel 

        11.5.3. By Country/Sub-region

12. Latin America Diabetes Devices Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast by Product Type, 2017–2027

        12.2.1. Glucose Monitoring Devices

            12.2.1.1. Self- monitoring blood glucose meters

            12.2.1.2. Blood glucose testing strips

            12.2.1.3. Lancets

            12.2.1.4. Continuous glucose monitoring meters

        12.2.2. Insulin Delivery Devices

            12.2.2.1. Insulin syringes

            12.2.2.2. Insulin pens

            12.2.2.3. Insulin pumps

        12.2.3. Diabetes Management Software

        12.2.4. Artificial Pancreas System

    12.3. Market Value Forecast by Distribution Channel, 2017–2027

        12.3.1. Hospital Pharmacies

        12.3.2. Retail Pharmacies

        12.3.3. Online Pharmacies

        12.3.4. Diabetes Clinics/Centres

    12.4. Market Value Forecast by Country/Sub-region, 2017–2027

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Market Attractiveness Analysis 

        12.5.1. By Product Type 

        12.5.2. By Distribution Channel 

        12.5.3. By Country/Sub-region

13. Middle East & Africa Diabetes Devices Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast by Product Type, 2017–2027

        13.2.1. Glucose Monitoring Devices

            13.2.1.1. Self- monitoring blood glucose meters

            13.2.1.2. Blood glucose testing strips

            13.2.1.3. Lancets

            13.2.1.4. Continuous glucose monitoring meters

        13.2.2. Insulin Delivery Devices

            13.2.2.1. Insulin syringes

            13.2.2.2. Insulin pens

            13.2.2.3. Insulin pumps

        13.2.3. Diabetes Management Software

        13.2.4. Artificial Pancreas System

    13.3. Market Value Forecast by Distribution Channel, 2017–2027

        13.3.1. Hospital Pharmacies

        13.3.2. Retail Pharmacies

        13.3.3. Online Pharmacies

        13.3.4. Diabetes Clinics/Centres

    13.4. Market Value Forecast by Country/Sub-region, 2017–2027

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Market Attractiveness Analysis 

        13.5.1. By Product Type 

        13.5.2. By Distribution Channel 

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player – Competition Matrix (by Tier and Size of companies)

    14.2. Market Share Analysis by Company (2018)

    14.3. Company Profiles

        14.3.1. Medtronic

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Growth Strategies

            14.3.1.3. SWOT Analysis

        14.3.2. Novo Nordisk A/S

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Growth Strategies

            14.3.2.3. SWOT Analysis

        14.3.3. Sanofi

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Growth Strategies

            14.3.3.3. SWOT Analysis

        14.3.4. Eli Lilly and Company

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Growth Strategies

            14.3.4.3. SWOT Analysis

        14.3.5. F. Hoffmann-La Roche Ltd.

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Growth Strategies

            14.3.5.3. SWOT Analysis

        14.3.6. Becton, Dickinson and Company

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Growth Strategies

            14.3.6.3. SWOT Analysis

        14.3.7. Tandem Diabetes Care, Inc

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.7.2. Growth Strategies

            14.3.7.3. SWOT Analysis

        14.3.8. Abbott Laboratories

            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.8.2. Growth Strategies

            14.3.8.3. SWOT Analysis

        14.3.9. Cellnovo

            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.9.2. Growth Strategies

            14.3.9.3. SWOT Analysis

        14.3.10. Medtronic0

            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.10.2. Growth Strategies

            14.3.10.3. SWOT Analysis

        14.3.11. LifeScan, Inc. 

            14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.11.2. Growth Strategies

            14.3.11.3. SWOT Analysis

        14.3.12. Owen Mumford Ltd.

            14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.12.2. Growth Strategies

            14.3.12.3. SWOT Analysis

List of Tables

Table 01: Global Diabetes Devices Market Size (US$ Mn) Forecast, by Product type, 2017–2027

Table 02: Global Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type –Glucose Monitoring Devices 2017–2027

Table 03: Global Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type– Insulin Delivery Devices, 2017–2027

Table 04: Global Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 05: Global Insulin Delivery Devices Market Size (US$ Mn) Forecast, by Region, 2017–2027

Table 06: North America Diabetes Devices Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 07: North America Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type, 2017–2027

Table 08: North America Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type –Glucose Monitoring Devices 2017–2027

Table 09: North America Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type– Insulin Delivery Devices, 2017–2027

Table 10: North America Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 11: Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 12: Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type, 2017–2027

Table 13: Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type –Glucose Monitoring Devices, 2017–2027

Table 14: Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type – Insulin Delivery Devices, 2017–2027

Table 15: Europe Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 16: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 17: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Product Type, 2017–2027

Table 18: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Glucose Monitoring Devices, 2017–2027

Table 19: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Insulin Delivery Devices, 2017–2027

Table 20: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 21: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 22: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by product type, 2017–2027

Table 23: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Glucose Monitoring Devices, 2017–2027

Table 24: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Insulin Delivery Devices, 2017–2027

Table 25: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 26: Middle East & Africa Diabetes Devices Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 27: Middle East & Africa Market Size (US$ Mn) Forecast, by product type, 2017–2027

Table 28: Middle East & Africa Diabetes Devices Market Size (US$ Mn) Forecast, by Glucose Monitoring Devices, 2017–2027

Table 29: Middle East & Africa Diabetes Devices Market Size (US$ Mn) Forecast, by Insulin Delivery Devices, 2017–2027

Table 30: Middle East & Africa Diabetes Devices Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027

List of Figures

Figure 01: Diabetes Devices Market, by Product, Market Size (US$ Mn), 2018 (A)

Figure 02: Diabetes Devices Market, by Distribution Channel, Market Share, 2018 (A)

Figure 03: Global Diabetes Devices Market Size (US$ Mn) Forecast, 2017–2027

Figure 04: Revenue Share (1)

Figure 05: Revenue Share (2)

Figure 06: Estimated Number of People with Diabetes Worldwide and Per Region in 2015 and 2040 (Age 20-79 years) 

Figure 07: Global Diabetes Devices Market Value Share, by Product Type, 2018 and 2027

Figure 08: Global Diabetes Devices Market Attractiveness, by Product Type, 2019–2027

Figure 09: Global Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2018 and 2027

Figure 10: Global America Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2018 and 2027

Figure 11: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Glucose Monitoring Devices, 2017–2027

Figure 12: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Insulin Delivery Devices, 2017–2027

Figure 13: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diabetes Monitoring Software, 2017–2027

Figure 14: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Artificial Pancreas System, 2017–2027

Figure 15: Global Diabetes Devices Market Value Share, by Distribution Channel, 2018 and 2027

Figure16: Global Diabetes Devices Market Attractiveness, by Distribution Channel, 2019–2027

Figure 17: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacy, 2017–2027

Figure 18: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacy, 2017–2027

Figure 19: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacy, 2017–2027

Figure 20: Global Diabetes Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diabetes Clinics/ Centers, 2017–2027

Figure 21: Global Market Scenario by Country (1/1)

Figure 22: Global Diabetes Devices Market Value Share Analysis, by Region, 2018 and 2027

Figure 23: Global Diabetes Devices Market Attractiveness Analysis, by Region, 2019–2027

Figure 24: North America Diabetes Devices Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 25: North America Diabetes Devices Market Attractiveness Analysis, by Country, 2019–2027

Figure 26: North America Diabetes Devices Market Value Share Analysis, by Country, 2018 and 2027

Figure 27: North America Diabetes Devices Market Value Share, by Product Type, 2018 and 2027

Figure 28: North America Diabetes Devices Market Attractiveness Analysis, by Product Type, 2019–2027

Figure 29: North America Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2018 and 2027

Figure 30: North America Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2018 and 2027

Figure 31: North America Diabetes Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 32: North America Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2018 and 2027

Figure 33: Europe Diabetes Devices Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 34: Europe Diabetes Devices Market Attractiveness Analysis, by Country, 2019–2027

Figure 35: Europe Diabetes Devices Market Value Share Analysis, by Country, 2018 and 2027

Figure 36: Europe Diabetes Devices Market Value Share, by Product Type, 2018 and 2027

Figure 37: Europe Diabetes Devices Market Attractiveness Analysis, by Product Type, 2019–2027

Figure 38: Europe Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2018 and 2027

Figure 39: Europe Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2019–2027

Figure 40: Europe Diabetes Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 41: Europe Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2018 and 2027

Figure 42: Asia Pacific Diabetes Devices Market Size (US$ Mn) Forecast, and Y-o-Y Growth (%) Forecast, by region, 2017–2027

Figure 43: Asia Pacific Diabetes Devices Market Attractiveness Analysis, by Country

Figure 44: Asia Pacific Diabetes Devices  Market Value Share Analysis, by Country, 2018 and 2027

Figure 45: Asia Pacific  Diabetes Devices Market Value Share Analysis, by Product type 2018 and 2027

Figure 46: Asia Pacific Diabetes Devices Market Attractiveness Analysis, by product type

Figure 47: Asia Pacific Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2018 and 2027

Figure 48: Asia Pacific Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2019–2027

Figure 49: APAC Diabetes Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 50: Asia Pacific Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2018 and 2027

Figure 51: Latin America Diabetes Devices Market Size (US$ Mn) Forecast, and Y-o-Y Growth (%) Forecast, by region, 2017–2027

Figure 52: Latin America Diabetes Devices Market Attractiveness Analysis, by Country

Figure 53: Latin America Market Value Share Analysis, by Country, 2018 and 2027

Figure 54: Latin America Market Value Share Analysis, by Product type 2018 and 2027

Figure 55: Latin America Diabetes Devices Market Attractiveness Analysis, by product type

Figure 56: Latin America Diabetes Devices Market Value Share, by Glucose Monitoring Devices,  2018 and 2027

Figure 57: Latin America Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2019–2027

Figure 58: Latin America Diabetes Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 59: Latin America Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2018 and 2027

Figure 60: Middle East & Africa Diabetes Devices Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast 2017-2015

Figure 61: Middle East & Africa Diabetes Devices Market Attractiveness Analysis, by Country, 2017-2025

Figure 62: Middle East & Africa Market Value Share Analysis, by Country, 2018 and 2027

Figure 63: Middle East & Africa Market Value Share Analysis, by Product type 2018 and 2027

Figure 64: Middle Diabetes Devices Market Attractiveness Analysis, by product type

Figure 65: Middle East & Africa Diabetes Devices Market Value Share, by Glucose Monitoring Devices, 2018 and 2027

Figure 66: Middle East & Africa Diabetes Devices Market Value Share, by Insulin Delivery Devices, 2019–2027

Figure 67: MEA Diabetes Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 68: MEA Diabetes Devices Market Attractiveness Analysis, by Distribution Channel, 2018 and 2027

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Diabetes Devices Market